Authors


Katelyn Carswell, PharmD Candidate 2023

Latest:

Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy Settings

Although pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.


Jake Galdo, PharmD, MBA, BCPS, BCGP

Latest:

Pediatric Weight is Crucial to Perfecting the Dose

Evidence indicates that up to 25% of all prescriptions for children could be dosed inappropriately, making it the most common type of medication administration error.


Lauren B. Krupp, MD, FAAN

Latest:

AAN 2025: Insights on Pediatric Multiple Sclerosis Treatment and Management

Lauren B. Krupp, MD, FAAN, provides comprehensive guidance on treating pediatric multiple sclerosis, emphasizing early intervention, high-efficacy therapies, and holistic family support.


Adam James, PharmD

Latest:

Key Takeaways to Prioritize in Practice

A panelist discusses key insights for pharmacists to prioritize, including staying informed about new respiratory syncytial virus (RSV) vaccines such as Arexvy and Abrysvo, educating patients on the benefits of vaccination, monitoring common adverse effects, ensuring timely access to vaccines, and playing a crucial role in supporting patient safety and prevention efforts for RSV.


Dan Landup, PharmD, HF-Cert

Latest:

Future Considerations for the Management of Hyperlipidemia

Panelists discuss how anticipated updates to cholesterol guidelines and related cardiovascular-kidney-metabolic health (CKM) guidelines this year are expected to shape low-density lipoprotein cholesterol (LDL-C) management strategies and influence treatment recommendations for high-risk patients.


Avital Gaziel, PhD

Latest:

AI Can Help Bridge Disparities in Cancer Care Through Digital Platforms

Collaboration between AI-based platforms and health care organizations offers promising results.


Rebecca Vales, PharmD Candidate

Latest:

Interactive Case Studies: September 2023

Cases highlight an acute subdural hematoma and chronic obstructive pulmonary disease.


Alaa Abdul Ghani, PharmD

Latest:

AI at the Counter: How Artificial Intelligence Is Shaping the Future of Pharmacy Practice

AI transforms pharmacy practice by streamlining workflows and enhancing patient care, while pharmacists adapt to new roles and challenges in health care.


Zak Nur, PharmD, CSP

Latest:

Zongertinib: A Promising New TKI for HER2-Mutated NSCLC

If approved, zongertinib may be a new first-line oral tyrosine kinase inhibitor (TKI) for patients with HER2-mutated non-small cell lung cancer (NSCLC), a transformative step in TKI drug development.


Matthew Busalacchi, PharmD

Latest:

Pharmacogenomics Offers a Glimpse Into the Future of Pharmacy

One day soon, including pharmacogenomics testing for all patients will be essential for precise prescribing.


Austin Paytes, PharmD

Latest:

Evaluation of Antibiotic Administration Surrounding Interventional Radiology Procedures

Implementation of a guidance document for periprocedural antibiotic prophylaxis resulted in improved appropriateness of antibiotic dose, selection, and duration for interventional radiology procedures.


Catherine B. Meador, MD, PhD

Latest:

Targeting DLL3 in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

DLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.


Karen M. Fancher, PharmD, BCOP

Latest:

Understanding the Role of Oncology Pharmacists in Academic vs Community Cancer Centers

Their expertise complements multidisciplinary teams in a variety of clinical settings.


Anna Xie, PharmD, BCPS, BCOP

Latest:

Staff Pharmacists Discuss Updated Carboplatin Drug Shortage Mitigation Strategies at the University of Illinois at Chicago Oncology Clinic Pharmacy

After carboplatin joined the growing list of drug shortages, staff pharmacists acted to minimize the impact on patients.


Victoria Fal

Latest:

Clinical Overview: Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Mavacamten is a first-in-class selective allosteric modulator of beta cardiac myosin ATPase for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.


Sarah E. Cabral, PharmD, BCOP

Latest:

Therapies in the Pipeline for Prostate Cancer

New potential medications may continue to expand the role of targeted agents.


Lyubov Villanueva, PharmD Candidate, and Shane Desselle, RPh, PhD, FAPhA

Latest:

Tip of the Week: We Are All Clinician-Managers

The evolution of health care to a more patient-centric focus suggests an even greater marriage between the concepts of manager and clinician.


Nadia Ward

Latest:

Microbiology Quality Control Helps the Cell and Gene Therapy Segment Cure the Incurable

With the continued advancement and approval of cell and gene therapies, the need for trustworthy microbiology quality control solutions is at an all-time high.


Patrick Hawthorne, BPharm

Latest:

How Can Pharmacies Close the Gap on Vaccine Uptake?

Pharmacists and the pharmacies they support are in a strong position to increase vaccination rates and address any questions related to vaccine hesitancy.


Dea Belazi, PharmD, MPh

Latest:

Critical Success Factors for Commercializing Specialty Drugs, Cell and Gene Therapies

Although payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.”


Warda Nawaz

Latest:

Once-Daily Oral Pill for Plaque Psoriasis Shows Promise

Deuvacracitinib (Sotyktu), which the FDA approved in September 2022, is a first-of-its-class tyrosine kinase 2 inhibitor and a member of the Janus kinase family.



Maddie N. Lee, PharmD/MPA Candidate

Latest:

Case Study: Review of ACE Inhibitor-Induced Bowel Angioedema

Globally, more than 40 million patients are currently taking an ACE inhibitor, primarily for the treatment of high blood pressure and heart failure.


Harry Shamamian, PharmD, MBA, FACHE

Latest:

Introducing Tarlatamab-dlle: A New Era in Oncology Treatment

The therapy offers new hope in solid tumor treatment with fewer adverse effects.


Atosa Nazemi, PharmD

Latest:

During Summer Months, Counsel Patients on Preventing Lyme Disease

Education about prevention measures and early signs and symptoms of the condition are crucial


Amy Carissa Oliver, CPM, FRAS

Latest:

Cancer Vaccine Trials With Canines May Benefit Cancer Prevention in Humans

The clinical trial success in canines may have broader implications for applicability.


Brandon McLain, PharmD, MBA, BCPS

Latest:

Standardizing Infusion Pumps in Large Health Systems Enhances Safety

Analyzing consolidation of 8 drug pump libraries into 1 IV infusion library in a 9-hospital system: from standardization to implementation.


Lena Jadrawi, PharmD Candidate

Latest:

Experiences With Racial and Ethnic Minority Patients Give Students Lessons Beyond the Classroom

Pharmacists can leverage their own identities to advocate for happier, healthier individuals within communities of different ethnic and socioeconomic backgrounds


Tashrique Rahman PharmD, MBA

Latest:

Mental Health Awareness is Vital Year-Round

As pharmacy professionals battle with their own challenges regarding mental health, the optimal role of psychiatric pharmacists is yet to be defined.


Maura Cantwell, PharmD Candidate

Latest:

Risks and Impacts of Cannabis Use During Pregnancy: A Growing Concern for Neonatal Health

Cannabis use during pregnancy may harm fetal development and long-term health.